Only the headline primary endpoint was a near miss. The hyperlipidimic population subset and multiple event analysis were great success. CSL still have a blockbuster on their hands.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$247.52 |
Change
0.070(0.03%) |
Mkt cap ! $119.7B | |||
| Open | High | Low | Value | Volume |
| $247.65 | $249.87 | $245.75 | $114.9M | 462.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 96 | $247.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $247.52 | 74 | 9 |
View Market Depth
| Last trade - 15.38pm 17/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |